US EditionDialogue and Humanism to Make Therapeutic Innovation Sustainable
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
The 'tsunami' of new drugs test the procedural and economic solvency of the National Health System (NSS). The challenge is not simple as part of certain shortcomings, but also of a gap between the market perspective and social value. Experts have it clear: the future for making models of evaluation and more sustainable access by signing a social contract composed of several clauses: dialogue, strengthening the role of hospital pharmacist in rese…
A Systematic Review and Quality Assessment of Pharmacoeconomic Publications for China Compared to Internationally: Is the Quality of Evidence-base Sufficient for Health Technology Assessment?
Background To summarize the quality of pharmacoeconomic publications for China compared to internationally and to identify areas for improvement both from a China-specific and international perspective. Methods First, we conducted a systematic review of pharmacoeconomic publications for China, with subsequent reporting quality assessment based on the CHEERS checklist. Second, we conducted an umbrella review of pharmacoeconomic publications int…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
